KA
AKRO icon

Kerrisdale Advisers’s Akero Therapeutics AKRO Stock Holding History

Kerrisdale Advisers’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-26,457
Closed -$659K – 64
2020
Q2 		$659K Sell
26,457
-1,643
-6% -$40.9K 0.07% 57
2020
Q1 		$596K Buy
+28,100
New +$596K 0.11% 50